RT @ProfEmmaCrosbie: See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial…
RT @ProfEmmaCrosbie: See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial…
RT @ProfEmmaCrosbie: See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial…
RT @ProfEmmaCrosbie: See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial…
RT @ProfEmmaCrosbie: See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial…
RT @ProfEmmaCrosbie: See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial…
RT @ProfEmmaCrosbie: See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial…
RT @ProfEmmaCrosbie: See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial…
See also our linked papers, showing the acceptability, costs & cost-effectiveness of universal testing of endometrial cancer for LS https://t.co/yGeDN3INRy https://t.co/WjtRsHdaKq https://t.co/nKYgrZJTer https://t.co/1QRxCtBwar https://t.co/uqRzO6b7lI
RT @TMSnowsill: After we conducted this analysis we got the results of @neilajryan's microcosting study (https://t.co/NbM6u9wyIG) and PETAL…
RT @Lynchsyndromirl: A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Canc…
RT @Lynchsyndromirl: A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Canc…
RT @Lynchsyndromirl: A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Canc…
A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips? https://t.co/XBOjAlGUu1
RT @TMSnowsill: After we conducted this analysis we got the results of @neilajryan's microcosting study (https://t.co/NbM6u9wyIG) and PETAL…
After we conducted this analysis we got the results of @neilajryan's microcosting study (https://t.co/NbM6u9wyIG) and PETALS. Some key findings were: costs considerably lower than used in DG27 and elsewhere; can successfully "mainstream" testing for Lynch
RT @promegauk: Read this excellent study which looks at the cost effectiveness of Lynch Syndrome testing strategies in the UK NHS https://t…
RT @promegauk: Read this excellent study which looks at the cost effectiveness of Lynch Syndrome testing strategies in the UK NHS https://t…
Read this excellent study which looks at the cost effectiveness of Lynch Syndrome testing strategies in the UK NHS https://t.co/XprC37cnuM In summary triage tumours with PCR-based #MSI reflex MLH1 methylation testing followed by germline #NGS of women wi
RT @DrEmmaCrosbie: Absolutely! Universal screening of #endometrial cancer for #Lynch syndrome will save lives through colorectal surveillan…
RT @DrEmmaCrosbie: Absolutely! Universal screening of #endometrial cancer for #Lynch syndrome will save lives through colorectal surveillan…
Absolutely! Universal screening of #endometrial cancer for #Lynch syndrome will save lives through colorectal surveillance and cascade testing of relatives. You can use our micro-costing paper to argue the case too! https://t.co/wyZI2fcKZ5
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @FrontOncology: A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @WombCancerUK: Great news. #wombcancer https://t.co/wQizSpoZMa
Great news. #wombcancer
"Lynch syndrome is the most common inherited cause of endometrial cancer. Identifying individuals affected by Lynch syndrome enables risk-reducing interventions including colorectal surveillance, and cascade testing of relatives." https://t.co/XBOjAlGUu1
A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips? https://t.co/XBOjAlGUu1
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @FrontOncology: A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer…
RT @FrontOncology: A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
RT @DrEmmaCrosbie: Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Cost…
Excited to announce our new paper showing that screening #endometrial #cancer for #LynchSyndrome is cheap as chips! Costs less than £50 per case! Time to change guidance - screening for Lynch syndrome saves lives! @neilajryan @TMSnowsill https://t.co/
RT @FrontOncology: A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer…
RT @FrontOncology: A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer…
A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips?: Neil A. J. Ryan, Niall J. Davison, Katherine Payne, Anne Cole, D. Gareth Evans, Emma J. Crosbie https: